A empresa DocCheck AG cotada na bolsa de valores está especializada no mercado em crescimento do Healthcare.


Fresenius Kabi is the leader in infusion therapy and clinical nutrition
in Europe and in its most important countries of Latin America and Asia
Pacific.
All over the world around 14,500 employees are committed to improving
the quality of life of critically- and chronically-ill patients with
innovative products for patients in hospitals and outpatients.